Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-109262
Filing Date
2024-10-16
Accepted
2024-10-16 17:15:00
Documents
4
Effectiveness Date
2024-10-16

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2426223d1_s8.htm S-8 75119
2 EXHIBIT 5.1 tm2426223d1_ex5-1.htm EX-5.1 7288
3 EXHIBIT 23.1 tm2426223d1_ex23-1.htm EX-23.1 2523
4 EX-FILING FEES tm2426223d1_ex-filingfees.htm EX-FILING FEES 20962
  Complete submission text file 0001104659-24-109262.txt   106915
Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

EIN.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
Type: S-8 | Act: 33 | File No.: 333-282682 | Film No.: 241375346
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)